08
082850.KQ Wooree Bio Co.Ltd
- Market cap
- KRW 36.8B
- P/E
- -
- P/B
- 0.17x
- ROE
- 1.9%
- Dividend yield
- 1.10%
- Fundamental score
- 1.3/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 082850.KQ undervalued?
Graham numberThe Graham number of Wooree Bio Co.Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wooree Bio Co.Ltd fundamental analysis
6 of 22 checks passedROE 0/2
Low return on equity (1.9%), below 10%.
ROA 0/1
Return on assets (0.5%) is below the industry median (4.5%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-1,088.2%) is below the industry median (-15.1%).
Revenue Growth 0/2
Revenue shrank 8.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (11.8%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
EBIT is 1.4x against interest expense, below 5x.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.2x) is below the industry median (1.1x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Wooree Bio Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wooree Bio Co.Ltd
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; surface mounting technology products; separators for secondary batteries; backlight parts for thin film transistor-liquid crystal displays; sells and assembles TVs; and TV and LCD monitor components. In addition, it provides health supplementary food; and provides natural materials for cosmetics, f…
Full company profileWooree Bio Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Wooree Bio Co.Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.53T | 1.47T | 1.28T | 1.67T | 1.62T | 1.54T | 1.36T | 1.26T | 1.24T | 1.04T | 1.17T |
| Gross Profit | 74.5B | 68.9B | 52.1B | 89.3B | 101B | 116B | 115B | 116B | 119B | 95.2B | 109B |
| Operating Income | -19.2B | -10.3B | -13.8B | 25.2B | 39.0B | 42.8B | 34.4B | 26.0B | 12.9B | 958M | -13.5B |
| EBITDA | - | - | - | - | - | - | 73.2B | 59.6B | 57.5B | 27.4B | 34.2B |
| Net Income | -40.2B | -12.5B | -32.9B | 4.53B | 16.8B | 33.2B | 21.8B | 15.6B | 4.74B | -9.37B | 3.99B |
| EPS | -998 | -310 | -817 | 104 | 386 | 725 | 467 | 330 | 100 | -993 | 423 |
| Balance Sheet | |||||||||||
| Total Assets | 818B | 613B | 605B | 610B | 646B | 664B | 559B | 586B | 610B | 762B | 873B |
| Total Liabilities | 689B | 483B | 517B | 517B | 535B | 509B | 380B | 334B | 398B | 501B | 610B |
| Shareholders' Equity | 129B | 130B | 88.0B | 93.4B | 111B | 155B | 179B | 199B | 212B | 205B | 213B |
| Cash & Short-term Investments | 46.7B | 45.1B | 24.0B | 36.6B | 90.4B | 115B | 126B | 123B | 108B | 107B | 128B |
| Total Debt | 161B | 103B | 121B | 114B | 96.5B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.95B | 27.7B | 10.8B | 65.8B | 69.4B | 50.2B | 43.4B | 26.5B | 36.2B | 34.8B | 40.3B |
| Capital Expenditure | 32.8B | 33.4B | 28.0B | 24.1B | 17.3B | 11.6B | 13.4B | 11.1B | 83.6B | 22.4B | 20.1B |
| Free Cash Flow | - | - | - | - | 51.3B | 37.4B | 29.9B | 15.4B | -47.3B | 12.4B | 20.2B |
| Ratios | |||||||||||
| ROE | -31.2% | -9.6% | -37.4% | 4.9% | 15.2% | 21.4% | 12.2% | 7.8% | 2.2% | -4.6% | 1.9% |
| ROA | -4.9% | -2.0% | -5.4% | 0.7% | 2.6% | 5.0% | 3.9% | 2.7% | 0.8% | -1.2% | 0.5% |
| Net Profit Margin | -2.6% | -0.8% | -2.6% | 0.3% | 1.0% | 2.1% | 1.6% | 1.2% | 0.4% | -0.9% | 0.3% |
| Debt to Equity | 1.25x | 0.79x | 1.38x | 1.22x | 0.87x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Wooree Bio Co.Ltd dividends
Wooree Bio Co.Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:5 on Sep 7, 2026.
Who owns Wooree Bio Co.Ltd
- Insiders 33.99%
- Institutions 0.90%
- Public & others 65.11%
- Shares outstanding 42.8M
- Free float 30.4M
Wooree Bio Co.Ltd company profile
- Company name
- Wooree Bio Co.Ltd
- Ticker
- 082850.KQ
- ISIN
- KR7082850009
- Exchange
- KOSDAQ
- Listed since
- Jul 29, 2005
- Sector
- Technology
- Industry
- Semiconductors & Semiconductor Equipment
- Employees
- 105
- Fiscal year end
- December
- Address
- 79, Seonggok-ro, Ansan-Si, South Korea
- Phone
- 82 3 1599 3100
- Website
- wooreebio.co.kr
About Wooree Bio Co.Ltd
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; surface mounting technology products; separators for secondary batteries; backlight parts for thin film transistor-liquid crystal displays; sells and assembles TVs; and TV and LCD monitor components. In addition, it provides health supplementary food; and provides natural materials for cosmetics, food, and functional supplement applications, as well as provides vertical farm services. The company was formerly known as Wooree ETI Co., Ltd. and changed its name to Wooree Bio Co.,Ltd in March 2019. Wooree Bio Co.,Ltd was founded in 2000 and is headquartered in Ansan, South Korea.
Wooree Bio Co.Ltd management
4- Ms. Jeon PungChief Exec. Officer · born 1954
- Mr. Sang-Yeol ParkChief Exec. Officer · born 1961
- Mr. Gi-Hyun ChaChief Financial Officer · born 1962
- Young-Ho ChoManaging Director · born 1958